ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 404 filers reported holding ENCOMPASS HEALTH CORP in Q1 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,556,000 | +2.0% | 263,432 | +7.1% | 0.05% | -2.0% |
| Q1 2021 | $20,154,000 | -1.1% | 246,077 | -0.1% | 0.05% | -5.6% |
| Q4 2020 | $20,375,000 | +23.7% | 246,400 | -2.8% | 0.05% | +1.9% |
| Q3 2020 | $16,466,000 | +1.1% | 253,394 | -3.6% | 0.05% | -7.0% |
| Q2 2020 | $16,281,000 | -4.4% | 262,894 | -1.1% | 0.06% | -24.0% |
| Q1 2020 | $17,025,000 | -2.0% | 265,886 | +6.0% | 0.08% | +29.3% |
| Q4 2019 | $17,369,000 | -16.7% | 250,746 | -23.9% | 0.06% | -18.3% |
| Q3 2019 | $20,847,000 | -55.1% | 329,440 | -55.1% | 0.07% | -53.0% |
| Q2 2019 | $46,457,000 | -38.0% | 733,225 | -42.9% | 0.15% | -39.6% |
| Q1 2019 | $74,988,000 | +2.1% | 1,284,042 | +7.8% | 0.25% | -6.7% |
| Q4 2018 | $73,464,000 | -25.8% | 1,190,662 | -6.2% | 0.27% | -2.2% |
| Q3 2018 | $98,968,000 | -15.5% | 1,269,632 | -26.6% | 0.27% | -19.9% |
| Q2 2018 | $117,150,000 | +0.8% | 1,729,918 | -14.9% | 0.34% | -0.9% |
| Q1 2018 | $116,238,000 | – | 2,033,203 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |